Philip P Boudreau sold $747K of Abbott Laboratories (ABT)

Executed Aug 8 2025, disclosed Aug 11 2025, 3 days later.

Value, as filed

$747K

5,550 sh × $134.55

Executed

Aug 8 2025

the trade date, as filed

Disclosed

Aug 11 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Philip P Boudreau EVP AND CFO profile →

Philip P Boudreau (EVP AND CFO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Abbott Laboratories (ABT). Across 1 priced purchase filing, the average 21-session return was -4.2% from execution and -5.4% from disclosure (delay-adjusted; derived). The largest single filing was $201K of ABT (2,200 sh × $91.50, as filed), executed Apr 23.

The name

ABT

Abbott Laboratories ABT · Healthcare · 65 filings in 24 months ticker →

Healthcare · Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Philip P Boudreau in ABT

ABTPURCHASE Abbott Laboratories $201K
2,200 sh × $91.50
Exec Apr 23
Filed Apr 27 · 5:34 PM ET